Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : China Warehouse- More Than Crockery -- Ignore unavailable to you. Want to Upgrade?

To: RealMuLan who wrote (4884)	5/24/2005 12:21:29 AM
From: RealMuLan	Read Replies (1) \| Respond to of 6370

[this sounds horrible<ng>]--"internal research by Monsanto showed that guinea pigs fed on the maize developed abnormalities." AFX News Limited EU demands all research data on Monsanto GM maize 05.23.2005, 10:45 AM ROME (AFX) - The European Food Safety Agency (EFSA) has demanded from Monsanto all the data the company has gathered on a GM maize product considered to be a risk to health. 'Monsanto has a duty to show us all its research on its MON 863 maize,' said Professor Giorgio Calabrese, a member of the EFSA. A report yesterday in the London-based Independent on Sunday said internal research by Monsanto showed that guinea pigs fed on the maize developed abnormalities. Among the points of concern raised in the internal report were kidney malformations and modifications of the blood indicating damage to the immune system. The newspaper report was rerun in the Italian press. Monsanto's MON 863 product is awaiting EU ratification, which must be granted by agriculture ministers, before it can be marketed. csg/ljm/jc/bam/har COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. forbes.com Monsanto response on MON 863 maize 90-day rat reeding study checkbiotech.org